Roque Basoalto, L Felipe Damiani, Yorschua Jalil, María Consuelo Bachmann, Vanessa Oviedo, Leyla Alegría, Emilio Daniel Valenzuela, Maximiliano Rovegno, Pablo Ruiz-Rudolph, Rodrigo Cornejo, Jaime Retamal, Guillermo Bugedo, Arnaud W Thille, Alejandro Bruhn
BACKGROUND: Prophylactic high-flow nasal cannula (HFNC) oxygen therapy can decrease the risk of extubation failure. It is frequently used in the postextubation phase alone or in combination with noninvasive ventilation. However, its physiological effects in this setting have not been thoroughly investigated. The aim of this study was to determine comprehensively the effects of HFNC applied after extubation on respiratory effort, diaphragm activity, gas exchange, ventilation distribution, and cardiovascular biomarkers...
October 18, 2023: Annals of Intensive Care